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Background: The γ-aminobutyric acid type A receptor (GABAAR) is the primary receptor mediating fast synaptic
inhibition in the brain and plays a critical role in modulation of neuronal excitability and neural networks. Previous
studies have demonstrated that ATP and its nucleotide analogs may regulate the function of GABAARs via
Ca2+-dependent intracellular mechanisms, which require activation of purinergic 2 (P2) receptors or cross-talk
between two receptors.
Results: Here, we report a potentiation of GABAARs by extracellular ATP via a previously un-recognized allosteric
mechanism. Using cultured hippocampal neurons as well as HEK293 cells transiently expressing GABAARs, we
demonstrate that extracellular ATP potentiates GABAAR mediated currents in a dose-dependent manner with an
EC50 of 2.1 ± 0.2 mM. The potentiation was mediated by a postsynaptic mechanism that was not dependent on
activation of either ecto-protein kinase or P2 receptors. Single channel recordings from cell-free excised membrane
patches under outside-out mode or isolated membrane patches under cell-attached mode suggest that the ATP
modulation of GABA currents is achieved through a direct action of ATP on the channels themselves and manifested
by increasing the single channel open probability without alteration of its conductance. Moreover, this ATP
potentiation of GABAAR could be reconstituted in HEK293 cells that transiently expressed recombinant rat GABAARs.
Conclusions: Our data strongly suggest that extracellular ATP allosterically potentiates GABAAR-gated chloride
channels. This novel mode of ATP-mediated modulation of GABAARs may play an important role in regulating neuronal
excitability and thereby in fine-tuning the excitation-inhibition balance under conditions where a high level of
extracellular ATP is ensured.
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The γ-aminobutyric acid type A receptor (GABAAR) is a
ligand-gated chloride ion channel, activation of which
results in membrane hyperpolarization and hence inhib-
ition of the neuronal excitability in the adult mammalian
brain. Dysfunction of GABAARs is associated with the
pathogenesis of a number of neurological diseases and
neuropsychiatric disorders such as epilepsy, Alzheimer
disease, and anxiety [1-6]. GABAARs are also targets of
many clinically-relevant drugs including benzodiazepine,* Correspondence: ytwang@brain.ubc.ca
1Brain Research Centre and Department of Medicine, Vancouver Coastal
Health Research Institute, University of British Columbia, Vancouver, BC V6T
2B5, Canada
2Translational Medicine Research Center, China Medical University Hospital,
Graduate Institute of Immunology, China Medical University, Taichung 40447,
Taiwan
Full list of author information is available at the end of the article
© 2014 Liu and Wang; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orbarbiturates and general anesthetics [7]. Moreover,
endogenously produced substances such as neuro-
steroids [8] and zinc [9,10] modulate GABAARs via
direct interaction with the putative binding sites on
the receptor subunit. Therefore, allosteric modula-
tion is an important mode in regulating GABAAR
functions and hence maintaining homeostasis for
neuronal excitability.
In the CNS, adenosine 5′-triphosphate (ATP) not only
acts as a major intracellular energy source and phosphate
donor, but also functions extracellularly as a neurotrans-
mitter via activation of purinergic 2 (P2) receptors.
Previous studies demonstrate that extracellular ATP
can modulate GABAAR function by activation of P2 re-
ceptors [11-13]. In addition, a physical cross-talk between
GABAARs and P2 receptors which influencess inhibition
of GABAAR-mediated currents has also recently beenl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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extracellular ATP inhibits the function of N-methyl-D-
aspartate (NMDA) glutamate receptors by directly bind-
ing to the receptor, suggesting that extracellular ATP
may function as an allosteric modulator for neurotrans-
mitter receptors [17].
High levels of ATP also exist in the extracellular com-
partment under both normal physiological conditions (i.e.
as result of synaptic release) [18-20], and pathological
conditions such as traumatic and ischemic brain insults
[21-24]. In addition, previous studies suggest that ATP
and GABA are released at GABAergic synapses [18,19,25].
Such a co-release suggests that, under certain conditions,
ATP could act as an allosteric modulator for postsynaptic
GABAARs. In the current study, we set out to investigate
this hypothesis by using both cultured hippocampal
neurons and HEK293 cells transiently expressing func-
tional recombinant GABAARs. We found that both ATP
and ADP can potentiate GABAAR-mediated currents.A
C
Figure 1 Extracellular ATP dose-dependently potentiates GABAAR-me
made from rat cultured hippocampal neurons. GABAAR-mediated currents
tip of a pipette positioned close to the neurons under recording. A, Bath a
171.9 ± 13.8% of the Control; P < 0.01; n = 7) and the potentiated currents r
Representative current traces were taken 5 min before and after drug appl
the dose-dependent potentiation of GABA currents by various concentratio
currents (normalized to Control) at the indicated ATP concentrations. The s
mean EC50 of 2.1 ± 0.3 mM and H of 1.66. C, ATP increases the amplitude of
individual traces of currents evoked by GABA (10 μM) in the absence (Control)
to +60 mV with a step of 20 mV. Right: current-voltage (I-V) relationships constMoreover, this potentiation effect appears to be mediated
by a direct binding of these nucleotides at a putative
nucleotide-binding site on the GABAAR.
Results
Extracellular ATP potentiates GABAAR-mediated currents
Under whole-cell voltage-clamp recordings of hippocam-
pal neurons at a holding membrane potential of -60 mV,
repetitive short pulses of pressure ejections of GABA
(100 μM) to the neuron evoked robust inward currents,
and these currents were mediated through GABAAR-gated
Cl- channels as they were completely blocked by bath ap-
plication of the GABAAR antagonist bicuculline (10 μM;
Figure 1A). Bath application of ATP at various concen-
trations produced a dose-dependent potentiation of the
GABA-evoked currents with an EC50 of 2.1 ± 0.2 mM
(n = 8; Figure 1A and B). At a concentration of 4 mM,
ATP increased the GABA-evoked currents to 171.9 ±
13.8% of the control (n = 7, P < 0.01). The potentiation ofB
diated currents in neurons. Whole-cell patch-clamp recording were
were evoked by a pulse pressure ejection of GABA (100 μM) from the
pplication of ATP (4 mM) reversibly potentiates GABA currents (ATP;
emained sensitive to bicuculline (10 μM) blockade (ATP + bicuculline).
ications or washout as indicated. B, The dose-response curve showing
ns of ATP (n = 8). Each data point represents the mean ± SEM of GABA
olid line is the best fit of the data to the Hill equation, which yields a
GABA currents without altering their reversal potential. Left: Superimposed
and presence of ATP (4 mM) at different holding potentials from -60
ructed from the data shown in the Left.
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the potentiated currents remained sensitive to bicuculliine
blockade (Figure 1A). Analysis of the current-voltage
(I - V) relationship in the absence and presence of ATP
within the range of holding potentials from -60 to +60 mV
showed that ATP significantly potentiated the peak am-
plitude of GABA currents without altering the reversal po-
tential (Figure 1C). Thus, extracellular ATP at mM ranges
can significantly potentiate the function of GABAARs.
Extracellular ATP potentiates currents mediated by both
synaptic and extrasynaptic GABAARs
Currents evoked by exogenously applied GABA could be
mediated by synaptic and/or extrasynaptic GABAARs.
To examine if ATP can modulate GABAARs localized
at the synapse, we examined effects of extracellularly
applied ATP on whole-cell recordings of miniature
postsynaptic inhibitory currents (mIPSCs) mediated byA
C
Figure 2 Extracellular ATP potentiates function of both synaptic and
A-C, ATP increases the amplitude (but not the frequency) of mIPSCs media
mediated mIPSCs were recorded under whole-cell voltage clamp mode at
traces taken 5 min before and after drug applications or washout showing
2 mM, but not 100 μM, potentiated mIPSCs. The potentiated mIPSCs were
returned to the control level after ATP washout. B, Cumulative amplitude a
shown in A before (black lines) and after (dotted lines) ATP application illu
of its frequency. C, Histogram summarizing averaged changes in the ampli
ATP (2 mM) from 7 individual neurons. All values were presented as percen
current. Tonic GABA currents were revealed by blocking native GABAARs w
presence (ATP 2 mM) of ATP in the extracellular recording solution. Left, Re
ATP taken from the same neuron 5 min before and after bath application o
from 6 individual neurons. ** P < 0.01.synaptic GABAARs. mIPSCs were recorded at a holding
membrane potential of -60 mV after blocking ionotropic
glutamate receptors with CNQX (20 μM) and AP-5
(50 μM), glycine receptor with strychnine (1 μM) and
sodium channels with TTX (1 μM). Suramin (100 μM)
and BBG (1 μM) were also added to the extracellular so-
lution to block P2 receptors. Similar to the observation
with evoked GABA currents above, extracellular appli-
cation of ATP at a concentration of 2 mM (but not
100 μM) significantly potentiated mIPSCs (Figure 2A
and B). These increased mIPSCs were abolished by
addition of bicuculline (10 μM), indicating that mIPSCs
following ATP remained entirely gated through GABAARs
(Figure 2A). The ATP enhancement of mIPSCs was
reversible, as it recovered to control levels after ATP and
bicuculline wash out (Figure 2A). Consistent with an ef-
fect on the postsynaptic GABAAR, but not on presynaptic
GABA release, ATP potentiation was manifested as aB
D
extrasynaptic GABAARs in cultured hippocampal neurons.
ted by synaptic GABAARs. Pharmacologically isolated GABAAR-
a holding potential of -60 mV. A, Representative continuous recording
dose-dependent effects of ATP on mIPSCs. ATP at a concentration of
fully blocked by additional application of bicuculline (10 μM) and
nd frequency distribution histograms of mIPSCs from the same cell
strating a specific increase in the mIPSC amplitude without alteration
tude and frequency of mIPSCs before (Control) and after application of
tage of the controls. D, Extracellular ATP increases the tonic GABA
ith addition of bicuculline (20 μM) in the absence (Control) and
presentative tonic GABA current traces in the absence and presence of
f ATP (2 mM). Bar graphs on the Right summarizing data obtained
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trol; p < 0.01; n = 7; Figure 2E), but not the frequency
(96.4 ± 3.3% of the control; p > 0.05; Figure 2E), of
mIPSCs. These results indicate that extracellular ATP po-
tentiates function of synaptic GABAARs, thereby increas-
ing the synaptic (phasic) currents mediated by these
receptors.
Next, to determine if ATP has a modulatory effect on
extrasynaptic GABAARs, thereby affecting tonic GABA
currents, we examined tonic GABA currents revealed by
the addition of bicuculline (20 μM) in the presence or
absence of ATP (2 mM ATP). As shown in Figure 2D,
bath application of bicuculline (20 μM) produced an
outward shift of the baseline current trace, indicating
that these tonic currents are gated largely through extra-
synaptically localized GABAARs activated by ambient
GABA under the recording conditions [26]. Following
addition of ATP (2 mM), bicuculline produced a sig-
nificantly larger outward shift of the holding current
(Figure 2D; 17.2 ± 2.7 pA in the presence of ATP vs 11.4 ±
1.8 pA in the absence of ATP; P < 0.01; n =6). Thus, extra-
cellular ATP appears capable of modulating both synaptic
and extrasynaptic GABAARs, thereby potentiating both
phasic and tonic GABA currents.
Extracellular ATP modulates GABAAR function via
mechanism of independent of ecto-protein kinases or
activation of P2 receptors.
Intracellular ATP is usually maintained at a few milli-
molar range (2-5 mM) at which it serves as a phosphate
donor to support regulation of GABAAR by protein
phosphorylation [27-29]. As extracellular (ecto-) protein
kinases have been previously demonstrated to phospho-
rylate neuronal membrane proteins such as P2X3 recep-
tors [30], we first examined the possibility that the ATP
potentiation of GABAAR function was a result of ecto-
protein kinase mediated phosphorylation by using AMP-A B
Figure 3 Potentiation of GABAAR-mediated currents by ATP and anal
receptors in cultured hippocampal neurons. Representative individual w
and after drug applications (100 μM, pulse-pressure ejection). A and B, AM
function as phosphate donor for ecto-protein kinase mediated phosphoryl
peak currents by 134.2 ± 11.4% (A; P < 0.05; n = 5) and 140 ± 14.7 (B; P < 0.0
(100 μM) and selective P2X7 receptor antagonist BBG (1 μM) suppressed ba
potentiating the currents; ATP increased the peak currents by 138.5 ± 16.5%PNP, a non-hydrolyzable analog of ATP that cannot sup-
port the protein phosphorylation process. As illustrated
in Figure 3A, AMP-PNP (2 mM) in the bath mimicked
ATP, increasing the amplitude of GABA currents
(Figure 3A; 134.2 ± 11.4%; P < 0.05; n = 5). Similarly, we
found that ADP (2 mM) was also able to significantly
potentiate GABA currents (Figure 3A; 140 ± 14.7;
P < 0.05; n = 7). As both AMP-PNP and ADP cannot
function as a phosphate donor during protein phospho-
rylation process, these results suggest that extracellular
protein phosphorylation is not likely involved in the
ATP potentiation of GABAAR-mediated currents.
As a neurotransmitter, at low concentrations (<100 μM)
ATP can activate a number of P2 receptors [31]. The fact
that extracellular ATP at this concentration has little po-
tentiating effect on GABAAR currents induced by either
exogenous (Figure 1) or endogenous GABA (Figure 2)
strongly suggests that activation of purinergic receptors is
unlikely to be responsible for the ATP potentiation of
GABA currents observed here. To further rule out the
potential involvement of activation of P2 receptors, P2
receptor antagonists were perfused prior to, and during
the application of ATP. At a concentration of 100 μM,
suramin (a broad-spectrum antagonist of P2 receptors)
blocks almost all P2 receptors, but has almost no effect on
P2X7 receptors [32,33]. BBG is a potent P2X7 receptor an-
tagonist with a very low IC50 (< 10 nM) [34,35]. As shown
in Figure 3C, although application of suramin (100 μM)
and BBG (1 μM) resulted in reduction of GABA currents
on their own, ATP (2 mM) was still able to potentiate
GABA currents in the presence of suramin and BBG
(Figure 3C). The mean amplitude of GABA currents was
increased to 138.5 ± 16.5% (n = 5; P < 0.05) of the control.
This suggests that the ATP potentiation of GABA currents
is not due to activation of P2 receptors. Together,
our results appear to reveal a previously undescribedC
ogs does not require activation of ecto-protein kinase or P2
hole-cell GABA current traces were taken 5 min before (Control)
P-PNP (2 mM; A) or ADP (2 mM; B), two ATP analogues that cannot
ation, remain capable of potentiating GABA currents, increasing the
5; n = 7), respectively. C, Non selective P2 receptor antagonist suramin
sal GABA currents on their own, but failed to prevent ATP from
(n = 5; P < 0.05) in the presence of both antagonists.
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is not dependent on either ecto-protein kinases or P2 re-
ceptor activation.
The enhancement of GABAAR function by extracellular
ATP is likely mediated by an allosteric mechanism
ATP may also allosterically modulate functions of many
proteins, including neurotransmitter receptors, by directly
binding to these proteins [17,36-38]. As an initial step to
test this possibility, we investigated the effect of extracellu-
lar ATP on GABAAR-gated single channel activities in
excised membrane patches under various modes of single-
channel recordings. Suramin (100 μM) and BBG (1 μM)
were added in the extracellular solution to block P2 recep-
tors. Under the outside-out mode at a holding potential
of –60 mV (Figure 4), no single channel activities were ob-
served in the absence of GABA. ATP alone (1 mM) did
not induce any detectable single channel currents (data
not shown). When 0.5 μM GABA was added to the extra-
cellular recording solution, single channel activities oc-
curred frequently, but were abolished by the addition ofA
B C
Figure 4 Extracellular ATP increases the open time of GABA single-ch
Outside-out GABAAR gated single channel activities were recorded by bath app
(A, Left) in absence (GABA; 0.5 μM) or presence of ATP (+ATP 1 mM) or ATP + b
Suramin (100 μM) and BBG (1 μM) were added in the bath throughout the reco
obtained 5 min before (GABA 0.5 μM) and after drug applications or washout a
(GABA) to 0.28 after addition of ATP. B, Current-voltage relationship of GABA sin
at various holding membrane potentials. C and D, Bar graphs summarizing the
of ATP (GABA+ATP) from seven cells. ** P < 0.01.bicuculline (10 μM) in the extracellular solution, con-
firming that the currents were gated through GABAARs
(Figure 4A). The mean single channel conductance and
open probability (Po) were 27 ± 0.85 pS and 0.18 ± 0.04
(n = 7), respectively. As shown in Figure 4A, co-applica-
tion of ATP (1 mM) significantly increased the Po of the
GABAAR-gated single-channel activities without altering
either main channel conductance or reversal potential
(Figure 4A and B). The mean Po and single channel con-
ductance in the presence of ATP were respectively 0.32 ±
0.06 (p < 0.01; n = 7; Figure 4C) and 27 ± 1.02 pS (P > 0.05;
n = 7). The changes in mean Po may result from altered
channel open times and/or frequency. Open time distri-
bution histograms revealed that the mean open time in
the presence of ATP was 11.3 ± 1.5 ms, which was sig-
nificantly different from the control (6.4 ± 1.1 ms; P < 0.05,
n = 7; Figure 4D). Although the frequency in the pre-
sence of ATP was slightly increased (control: 2.6 Hz vs.
ATP: 3.0 Hz), it was not significantly different from the
control (P > 0.05; n = 7). These results suggest that ATP
potentiation of GABA currents is achieved by anD
annel activity in outside-out mode in hippocampal neurons.
lication of GABA (0.5 μM) to the excised patches through bath applications
icuculline (+bicuculline 10 μM) in the bath or after drug washout (Washout).
rding to block P2 receptors. A, Representative GABA current traces were
s indicated above traces. In this patch, Po increased from 0.15 in the control
gle channel activity in the absence (Control) and presence of ATP (1 mM)
mean Po (Left) and open times (Right) in the absence (GABA) and presence
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open times.
The observation that potentiation can be detected in
the excised patches under outside-out mode is consis-
tent with the idea that ATP is not dependent on any dif-
fusible intracellular signaling molecule. Thus, ATP may
exert its modulating effects by directly acting on the
GABAAR itself, or on a protein that is tightly associated
with the GABAAR. This idea was further supported by
single-channel recordings under the on-cell attached
configuration. In this mode, GABA (0.5 μM) was added
to the recording solution in the pipette to selectively
activate GABA single channels within the pipette tip
(Figure 5A). Bath perfusion of ATP (1 mM) outside of the
recording pipette had little effect on single channel acti-
vities (Figure 5A and B; the mean Po and the main channel
current amplitude being 0.08 ± 0.02 and 1.66 ± 0.2 pA in
the presence of ATP and 0.07 ± 0.02 and 1.64 ± 0.2 pA in
the absence of ATP; P > 0.05, n = 5). However, application
of ATP (1 mM) along with GABA (0.5 μM) into the re-
cording pipette solution resulted in a significant increase
in the mean Po (Po: 0.19 ± 0.04; P < 0.01, compared withA
Figure 5 Extracellular ATP increases GABA single-channel open time
underneath the tip of the recording pipette were specifically activated by i
holding membrane potential of 0 mV. A, Representative current traces reve
when it was included through the recording pipette. Bar graphs on the Rig
(C) averaged from 5 individual recordings in the absence (Control) and pre
(ATP outside pipette) or inside the pipette by its inclusion in the pipette sothat in the absence of ATP; n = 6; Figure 5A and B) and
was similar to that observed under the outside-out mode,
leading to a significant increase in the mean open times
(Figure 5C; 7.7 ± 0.8 ms in the presence of ATP vs
4.6 ± 0.4 ms in the absence of ATP; P > 0.01, n = 5).
Together, single channel results from both outside-out
and on-cell modes support the notion that ATP poten-
tiates GABA currents, likely via a mechanism of allosteric
modulation.
To further explore this possible allosteric modulation
via a direct binding to the GABAAR itself, we finally
examined the ability of extracellular ATP and its analogs
to potentiate the function of recombinant GABAARs
transiently expressed in HEK293 cells in the absence of
other known neuronal proteins. GABAARs are pentameric
hetero-oligmers assembled from various distinct subunit
combinations. Although more than sixteen distinct sub-
units have been identified, most native GABAARs in the
mammalian brain consist of 2α, 2β and 1γ subunits
[1,39]. We transiently expressed recombinant rat α1β2γ2
GABAARs, the most abundant composition of native
GABAAR subtypes in the mammalian brain [39]. NeitherB
C
in cell attached mode. GABAAR channels in the patch membrane
nclusion of GABA (0.5 μM) in the intra-pipette recording solution at a
aling that ATP (1 mM) increased the GABA single-channel activity only
ht summarize the mean open probability (Po; B) and open times
sence of ATP (1 mM) outside the pipette in the bath solution
lution (ATP inside pipette). ** P < 0.01.
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detectable currents in HEK293 cells. Fast perfusion of
GABA (3 μM) reliably produced inward currents, which
were blocked by 10 μM bicuculline, indicating the currents
were mediated by bicuculline sensitive GABAAR-mediated
chloride-gated ion channels (Figure 6A). Co-perfusion of
GABA (3 μM) and ATP at various concentrations resultedA
B C
D
Figure 6 Extracellular ATP and ADP potentiates function of
recombinant GABAARs. Whole-cell voltage-clamp recordings were
performed in HEK293 cells transiently expressing rat recombinant α1β2γ2
GABAARs at a holding membrane potential of -60 mV. GABA currents
were induced by fast perfusion of GABA at various concentrations.
A, Representative current traces showing the potentiation of GABA
(3 μM) currents by co-perfusion of ATP (0.5 mM). The increased current
was blocked in the presence of bicuculline (10 μM) and returned to the
control level after ATP washout. B, The dose-response curve showing the
dose-dependent potentiation of the GABA (3 μM) currents by various
concentration of ATP. All values were normalized to the maximal GABA
currents (Imax) induced at 3 mM of ATP. Each data point is the mean ±
SEM of normalized GABA currents at the indicated ATP concentrations
(n = 6). The solid line is the best fit of the data to the Hill equation. The
EC50 and H were 390 ± 48 μM and 1.66 ± 0.1, respectively. C, ATP
potentiation of GABAAR activity is GABA dose-dependent. GABA dose-
response curves were constructed in the absence (Control) and presence
(ATP) of ATP (0.5 mM) from five cells. ATP shifted the curve to the left
and reduced EC50 from 11.6 ± 3.3 μM to 5.8 ± 2.1 (P < 0.01) without
change in H (control: 1.57 ± 0.1; ATP: 1.62 ± 0.1; P > 0.05). All values were
normalized to the Imax induced by GABA (300 μM). D, ADP mimics ATP,
potentiating the activity of recombinant GABAARs. Representative current
traces showed that application of ADP (0.5 mM) reversibly increased
currents induced by GABA (3 μM). On average, it increased the currents
by 147.5 ± 15.9% (P < 0.01; n = 5).in a significant increase in the peak amplitudes in a dose-
dependent manner, with a minimum concentration of ap-
proximately 100 μM and a maximum concentration of
greater than 2 mM (Figure 6A and B; n = 6). At a con-
centration of 0.5 mM, ATP increased the GABA currents
to 138.7 ± 14.2 of the control value (Figure 6A and B;
P < 0.05, n = 6). The potentiated currents were completely
abolished by bicuculline (10 μM; Figure 6A), and reco-
vered to control levels after washing out ATP (Figure 6A).
This ATP potentiation is also GABA concentration
dependent. As shown in Figure 6C, in the absence of
ATP, GABA produced currents in a dose-dependent
manner with the EC50 and Hill coefficient (h) being
respectively 11.6 ± 3.3 μM and 1.66 ± 0.1 (n = 5). Bath
application of ATP (0.5 mM) caused a left shift of the
GABA dose-response curve, reducing the EC50 to 5.8 ±
2.1 μM without altering the h (1.62 ± 0.1). Similar to
observations obtained in neurons, the ATP potentiation
of GABAARs was also mimicked by ADP. We found that
bath application of ADP (2 mM) increased GABA
currents by 147.5 ± 15.9% of the control (P < 0.01, n = 5;
Figure 5D). Thus, similar to native GABAARs in neurons,
recombinant rat GABAARs overexpressed in HEK293 cells
are also subject to potentiation by extracellular ATP.
These results therefore provide additional support for the
notion that ATP modulation of GABAARs through an
allosteric mechanism that does not require other neuronal
proteins.
Discussion
The modulation of GABAAR function by extracellular
ATP observed here is unlikely to require activation of
P2Y receptors, as was previously reported in rat cerebel-
lar granule cells [13]. First, Saitow and colleagues found
that ADP potentiation of postsynaptic GABAAR-me-
diated currents was long-lasting and could be demon-
strated at a much lower ADP concentration (within tens
of micromoles). In our study, the potentiating effect of
ATP or ADP on GABA currents was transient and re-
versible, quickly returning to baseline level upon ATP
washout. Moreover, ATP potentiation was only observed
at concentrations above 100 μM. Second, it is well estab-
lished that suramin at a concentration of 100 μM can
block the majority of P2 receptors (with the exception of
P2X7 receptors) and that BBG has a very high affinity
for the P2X7 receptor with an IC50 of 10 nM to 0.2 μM
[35]. We found that the potentiating effect of ATP or
ADP on GABA currents was not blocked by suramin
(100 μM) and BBG (1 μM).
It has been speculated that cross-talk between GABAA
and P2X receptors may play in a role in ATP regulation
of GABAARs. Although underlying mechanisms remain
controversial, recent studies suggest that it depends on
elevated [Ca2+]i [12,16] (but, also see [16]). However,
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talk is unlikely to be responsible for the ATP poten-
tiation of GABAAR function observed in the present
study, as blockade of P2 receptors had little effect,
and the BAPTA (10 μM) included in our intracellular
recording solution should be sufficient to prevent the
[Ca2+]I-dependent processes proposed in these earlier
studies.
Ecto-protein kinases have been identified in the CNS
and can modulate functions of membrane receptors
such as P2X3 receptors [30]. However, in the present
study we demonstrated that both AMP-PNP and ADP
mimicked the effects of ATP, potentiating the function
of GABAARs. As both of AMP-PNP and ADP cannot
substitute ATP in supporting the protein phosphory-
lation reaction, these results can essentially rule out the
involvement of ecto-protein kinase mediated ex extracel-
lular protein phosphorylation.
ATP is also known to function as an allosteric
modulator for a number of proteins by directly binding
to these proteins, regulating their functions. These pro-
teins include CFTR (Quinton PM, Reddy MM., 1992),
GABAARs [40], InsP3 receptors [37,41], and capsaicin-
activated ion channels [42]. But, in most of these cases,
ATP binds to the intracellular domains of these proteins.
Whether extracellular ATP can allosterically modulate
GABAARs via a direct binding to the extracellular do-
mains of the receptor has not previously been suggested.
Here, we provide several pieces of evidence that are
consistent with such a mode of regulation. First, using re-
combinant rat GABAARs transiently expressed in HEK293
cells, we were able to demonstrate that extracellular
ATP can potentiate the function of these recombinant
GABAARs in a manner similar to observations obtained
with native GABAARs in neurons, suggesting that the
ATP modulation does not require any additional neuronal
specific proteins other than GABAARs themselves.
Second, ATP potentiation could be demonstrated in the
excised cell-free membrane patches under the outside-out
configuration in neurons (Figure 4). These results indicate
that the potentiation of GABAARs by extracellular ATP
does not require any diffusible second messenger mol-
ecule downstream of an unknown metabotropic receptor,
thereby providing strong support for a direct binding of
ATP or its analog to an extracellular domain of GABAAR
itself, or a membrane surface protein tightly associated
with the receptor. Finally, this notion is further streng-
thened by our results obtained with single-channel recor-
dings under the on-cell attached configuration (Figure 5).
Under this configuration, currents through single or very
few GABAAR channels in the membrane patch under-
neath of the tip of the recording pipette can be recorded
in isolation from GABAARs outside of the pipette tip by
applying GABA to the isolated membrane patch throughthe recording pipette solution. Using this configuration,
we were able to demonstrate that the GABAAR single
channel activities from the isolated membrane patch in-
side of the recording pipette can only be potentiated by
ATP applied into the patch membrane through the re-
cording pipette solution, but not by that applied extracel-
lularly to the plasma membrane outside of the recording
pipette tip (Figure 5). Together, the present study provides
strong evidence supporting a novel mode of modulation
of GABAARs by extracellular ATP; allosteric modulation
likely achieved by either a direct binding of ATP to the re-
ceptor itself, or to an unknown protein tightly associated
with the receptor. Nonetheless, given that extracellular
ATP may potentially penetrate the plasma membrane, the
possibility that ATP potentiates GABAAR function by a
direct action on an intracellular domain of the receptor
remains to be ruled out. Thus, the ultimate evidence for
such a novel allosteric modulation will only come from
the positive identification/characterization of the novel
binding site (s) on GABAAR domain (s) or to identify
the receptor associated protein by which ATP acts. In
addition, whether the potentiation of GABAARs by ATP is
state-dependent remains to be determined.
How ATP binding modulates the GABAAR remains to
be determined. ATP binding may cause a conformational
change to the GABAAR, thereby affecting its agonist
binding affinity, channel gating, or both. Using various
modes of single-channel recordings and analysis, in the
present study we observed that extracellular ATP can
increase GABAAR-gated channel activities by primarily
increasing the channel open times without altering its
conductance. This may suggest that ATP binding pre-
dominantly alters the apparent agonist binding affinity
to the receptor, rather than the conformational change
of the channel pore. This conjecture is further streng-
thened by the GABA dose-response relationship analysis
from HEK293 cells as extracellular ATP results in a left-
shift of the GABA dose-response curves without altering
either h coefficient or the maximal responses (Figure 6B).
Future site-direct mutations of the putative ATP binding
domain along with direct ATP binding assays may pro-
vide a better understanding of the detailed mechanisms
by which ATP exerts its modulation of the GABAAR.
In the mammalian brain, GABAARs play a key role in
regulating the excitation-inhibition balance (and hence
the tight control of neuronal excitability), and this func-
tion is primarily realized by mediating synaptic (phasic)
inhibition and tonic inhibition [26]. In the present study,
we demonstrated that application of extracellular ATP at
millimolar concentrations not only potentiates GABA
currents evoked by exogenously applied GABA, but also
both synaptic and tonic currents activated by endo-
genous GABA. These results suggest that extracellular
ATP has significant physiological and/or pathologic
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To this end, it is relevant to point out that several previous
studies have suggested that under normal conditions, the
extracellular ATP in the CNS is approximately 1-100 μM
[25]. At such a low level, the basal extracellular ATP may
have little influence on neuronal excitability via GABAARs.
However, it is important to note that ATP has previously
been shown to be co-localized with GABA in the same
vesicles at certain GABAergic synapses, and more impor-
tantly, that these two transmitters can be co-released into
the synaptic cleft [18,19,25], whereby ATP concentrations
can transiently reach the levels above hundreds of micro-
moles or even millimolar concentrations. In the present
work, we demonstrated that at these concentrations, extra-
cellular ATP can potentiate GABAAR-mediated mIPSCs.
The fact that ATP potentiation of mIPSCs is primarily
manifested as a specific increase in mIPSC amplitude,
without altering its frequency, is in good agreement with
the allosteric modulation of postsynaptic GABAARs.
Thus, this mode of modulation may function at certain
GABAergic synapses under physiological conditions.
Similarly, the modulation may also occur under patho-
logical conditions (including neuronal overexcitation,
epileptic episodes, inflammation, traumatic insults, hyp-
oxia/ischemia), as ATP release from damaged neurons
and astrocytes can rapidly increase extracellular ATP
concentrations [21-24]. ATP may increase both phasic
and tonic GABA currents by acting on both synaptic
and extrasynaptic GABAARs. By forming such a ho-
meostatic feedback loop, under pathological conditions
extracellular ATP may exert significant impacts on
neuronal function and/or dysfunction. However, a related
caveat is the potential complication from acidosis that is
often associated with high concentrations of extracellular
ATP. Given that acidosis is known to reduce GABAAR
activity, how it will impact this ATP-induced allosteric
potentiation warrants future investigations.
Conclusions
In this study, we demonstrate that extracellular ATP and
its analogs such as ADP can potentiate function of
GABAARs via a novel mechanism likely involving the
direct binding of ATP to a putative ATP-binding site on
the GABAAR itself. We demonstrate that through this
modulation, extracellular ATP can enhance both phasic
(synaptic) and tonic GABAAR-mediated currents. There-
fore, the present study reveals a novel means by which
extracellular ATP contributes to regulating excitation-
inhibition balance and neuronal excitability under certain
physiological and pathological conditions. In addition, due
to the importance of GABAARs in mediating neuronal in-
hibition in the brain, they have been a major therapeutic
target for the development of many drugs currently used
for the clinical treatment of brain disorders. Furtheridentifying the exact putative binding site of ATP on
GABAARs may lead to the development of novel
GABAAR-based therapeutics for better management of
these brain disorders.
Materials
Primary culture of hippocampal neurons
Methods for culturing hippocampal neurons have been
described previously [43]. Briefly, hippocampi from E18
old Wistar rat embryos were dissected and treated with
0.25% trypsin solution (Invitrogen) for 25 min at 37°C,
then mechanically dissociated using fire-polished pasteur
pipettes. Cell suspension was centrifuged at 2500 × g for
50 s and the cell pellets were resuspended in DMEM
with 10% fetal bovine serum (FBS). Cells were seeded on
poly-D-lysine-coated 24-well coverslips at a density of
0.8-1.0 × 105 cells/well. Cultures were maintained in a
humidified incubator with 5% CO2 at 37°C. After 24 h,
the plating medium was changed to Neurobasal medium
supplemented with B-27 and L-glutamine (0.5 mM) and
neurons were fed with fresh medium twice weekly.
Experiments were done 14-18 days after the plating.
Expression of recombinant GABAA receptors in HEK293
cells
Human embryonic kidney (HEK) 293 cells were cultured
as previously described [44]. Briefly, HEK293 cells were
cultured in DMEM supplemented with 10% FBS. Cells
were harvested weekly and seeded at 10% confluence on
poly-L-lysine-coated glass coverslips in 24-mm culture
dishes. Cells were transiently co-transfected at 70% con-
fluence with rat cDNAs encoding α1, β2 and γ2-EGFP
subunits of the GABAA receptor at a 1:1:1 ratio using
Lipofectamine2000 (Invitrogen, Carlsbad, CA). Recor-
dings were made 24-48 h after transfection.
Whole-cell patch clamp recording
Coverslips were transferred to the recording chamber
and were continuously perfused with an extracellular
solution containing the following (in mM): NaCl 140,
KCl 5.4, MgCl2 1.3, HEPES 25, CaCl2 1.3, glucose 20,
pH 7.35-7.45, 305-315 mOsm. Recordings were per-
formed in the voltage-clamp mode using an Axopatch
200B patch-clamp amplifier (Axon Instruments). The
cell membrane were held at a potential of -60 mV and
signals were filtered at 2 KHz, digitized at 10 KHz using
a Digidata 1322A analog-to-digital converter and ac-
quired by Clampex 9.2 (Axon Instruments). Recording
electrodes (3–5 M) were fabricated from thin-walled
borosilicate glass tubing (World Precision Instruments,
USA) with a micropipette puller (Sutter Instruments,
model P-97, Novato, CA). Recording pipettes were filled
with an intracellular solution containing (in mM): CsCl
140, HEPES 10, 1,2-bis (2-aminophenoxy) ethane-N, N,
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314 5, pH 7.20; osmolarity, 290-295 mOsm. CNQX
(20 μM), AP-5 (50 μM) and tetrodotoxin (TTX, 0.5 μM)
were included in the external solution to block gluta-
matergic and the voltage-gated sodium channels. All
experiments were performed at room temperature.
Induction of GABAAR-mediated currents
Glass pipettes were filled with GABA (100 μM) dissolved
in the extracellular recording solution. The pipette tip
was placed in the vicinity of recorded neurons. GABA
was applied via pressure ejection using a Picospritzer
(General Valve Corporation, Fairfield, NJ) at 60 sec in-
tervals. For recording of GABA currents in HEK293
cells, fast perfusion of GABA and/or other ligands were
employed using a computer-controlled multibarrel fast
perfusion system (Warner Instruments). For some of the
experiments using bath perfusion of ATP or ADP, 5 mM
EGTA was added into Ca2+-free extracellular solution to
further reduce residual Ca2+ in extracellular solution,
thereby minimizing any potential effect of ATP/ADP-
induced extracellular Ca2+ influx. Under our experi-
mental conditions in cultured neurons, the Ca2+-free
solution neither produced any observable current on its
own nor significantly affected GABAAR-gated currents
(1 μM GABA; -648 ± -245pA in control solution
vs -677 ± -256pA in Ca2+-free solution supplemented
with 5 mM EGTA; n = 7; p < 0.05).
mIPSCs and GABA tonic current recording and analysis
GABAA receptor-mediated miniature inhibitory post-
synaptic currents (mIPSCs) were recorded at a holding
potential of −60 mV. CNQX (20 μM), APV (50 μM) and
TTX (1 μM) were added to the extracellular solution to
isolate GABAergic mIPSCs. Before drug application, a
3-5 min period of baseline recording (control) was ob-
tained. The recordings were low-pass filtered (Clampfit
software) at 2 kHz, digitized at 10 KHz using a Digi
data 1322A analog-to-digital converter and acquired by
Clampex 9.2. Detection and analysis of mIPSCs were
performed using Mini Analysis Program (Synaptosoft,
Decatur, GA). Any spurious noise was rejected. The
mIPSC kinetics were obtained from analysis of the aver-
aged single events. To facilitate analysis, decay time con-
stant (τD) was obtained by fitting the decay phase to a
single exponential equation. Tonic GABA current was
estimated as the change in baseline current produced by
a 2 min application of bicuculline (20 μM).
Single channel analysis
Patch pipettes for cell-attached and outside-out single
channel recordings were pulled from thick-wall borosili-
cate glass (GC150F, Harvard Apparatus), fire polished,
and coated with Sylgard 184 (Dow Corning) with aresistance of 6-10 MΩ. For outside-out recordings, the
recording pipette was filled with the intracellular solu-
tion at a holding potential of – 60 mV. GABA (0.5 μM)
was added to the external solution to activate GABAARs.
In cell-attached patch mode, the composition of the pip-
ette solution was (in mM): KCl 120, TEA-Cl 20, 1.3
MgCl2, HEPES 10, pH 7.40, 290-300 mOms. GABA
(0.5 μM) or GABA (0.5 μM) and ATP (1 mM) were in-
cluded in the pipette solution. Signals were filtered at
1 kHz, sampled at 10 kHz and analyzed off-line using
Clampfit 9.2. An idealized recording of the durations
and amplitudes of detectable events of the single-
channel data was generated using 50% threshold cros-
sing criteria. Events with a duration less than 300 μs
were ignored. Single channel activities were expressed as
the product of the number of channels × the open prob-
ability (Po); i.e. NPo = ∑[(open time × number of channels
open) ∕ total time of record].
Drugs
Drugs used in the present study were purchased from
the following sources: nucleotides (ATP, UTP, GTP,
ADP, UDP, GDP, AMP, UMP, GMP), GABA and bicu-
culline (Sigma-Aldrich); suramin, CNQX, APV, PPADS
(Tocris); and TTX (Alomone Labs).
Statistical analysis
Data is presented as means ± SEM, where n represents the
number of tested cells. One-way ANOVA or the two-
tailed Student’s test was used for statistical analysis and
P values less than 0.05 were considered statistically signifi-
cant. Dose–response curves were constructed by fitting
data to the Hill equation: I = Imax/(1 + EC50 / [A]
n), where
I is the current, Imax is the maximum current, [A] is a
given concentration of agonist, n is Hill coefficient (H).
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